Alliqua sells TheraBond line

 - 
Friday, September 8, 2017

YARDLEY, Pa. – Alliqua BioMedical has sold its TheraBond 3D Antimicrobial Barrier Systems product line to Argentum Medical, a manufacturer of metallic silver-based, antimicrobial wound dressings, for approximately $.38 million, it announced Sept. 5. Alliqua will use sale proceeds for working capital purposes and to reduce its outstanding debt balance. Argentum is a portfolio company of Shore Capital Partners, a private equity firm.